GH Research (NASDAQ: GHRS) COO details multiple share option grants

Rhea-AI Filing Summary

GH Research PLC filed an initial ownership report for Chief Operating Officer Cameron Aaron Luke, detailing his holdings of share options over Ordinary Shares. These options give him the right to buy Ordinary Shares at preset exercise prices before their expiration dates.

He holds options over 33,211 underlying Ordinary Shares at an exercise price of $21.3200 per share expiring on August 30, 2029, 17,500 shares at $0.0250 expiring on April 27, 2030, 25,000 shares at $5.8000 expiring on January 1, 2032, 200,000 shares at $0.0250 expiring on November 25, 2031, and 100,000 shares at $0.0250 expiring on May 16, 2032.

Footnotes state that one grant is already fully vested and exercisable, while the others vest 25% on specified dates, with the remaining 75% vesting in equal monthly installments over three years.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider Cameron Aaron Luke

Role Chief Operating Officer

Type	Security	Shares	Price	Value
holding	Share Options (Right to Buy)	--	--	--
holding	Share Options (Right to Buy)	--	--	--
holding	Share Options (Right to Buy)	--	--	--
holding	Share Options (Right to Buy)	--	--	--
holding	Share Options (Right to Buy)	--	--	--

Holdings After Transaction: Share Options (Right to Buy) — 33,211 shares (Direct)

Footnotes (1)

1. The share options are fully vested and exercisable. The share options vested as to 25% on April 27, 2024, and the remaining share options vest in equal monthly installments for three years thereafter. The share options vested as to 25% on January 1, 2025, and the remaining share options vest in equal monthly installments for three years thereafter. The share options vested as to 25% on November 25, 2025, and the remaining share options vest in equal monthly installments for three years thereafter. The share options vest as to 25% on May 16, 2026, and the remaining share options vest in equal monthly installments for three years thereafter.

Key Figures

Option grant 1 underlying shares: 33,211 shares Option grant 1 exercise price: $21.3200/share Option grant 2 underlying shares: 17,500 shares +3 more

6 metrics

Option grant 1 underlying shares 33,211 shares Underlying Ordinary Shares, exercise price $21.3200, expires August 30, 2029

Option grant 1 exercise price $21.3200/share Share Options (Right to Buy) over 33,211 Ordinary Shares

Option grant 2 underlying shares 17,500 shares Underlying Ordinary Shares, exercise price $0.0250, expires April 27, 2030

Option grant 3 underlying shares 25,000 shares Underlying Ordinary Shares, exercise price $5.8000, expires January 1, 2032

Option grant 4 underlying shares 200,000 shares Underlying Ordinary Shares, exercise price $0.0250, expires November 25, 2031

Option grant 5 underlying shares 100,000 shares Underlying Ordinary Shares, exercise price $0.0250, expires May 16, 2032

Key Terms

Share Options (Right to Buy), Ordinary Shares, exercise price, vested and exercisable, +1 more

5 terms

Share Options (Right to Buy) financial

"security_title: "Share Options (Right to Buy)""

Ordinary Shares financial

"underlying_security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"conversion_or_exercise_price: "21.3200""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vested and exercisable financial

"The share options are fully vested and exercisable."

equal monthly installments financial

"the remaining share options vest in equal monthly installments for three years thereafter"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Cameron Aaron Luke

(Last) (First) (Middle)

C/O GH RESEARCH PLC, JOSHUA DAWSON HOUSE

DAWSON STREET

(Street)

DUBLIN D02 RY95

(City) (State) (Zip)

IRELAND

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
GH Research PLC [ GHRS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Options (Right to Buy)	(1)	08/30/2029	Ordinary Shares	33,211	$21.32	D
Share Options (Right to Buy)	(2)	04/27/2030	Ordinary Shares	17,500	$0.025	D
Share Options (Right to Buy)	(3)	01/01/2032	Ordinary Shares	25,000	$5.8	D
Share Options (Right to Buy)	(4)	11/25/2031	Ordinary Shares	200,000	$0.025	D
Share Options (Right to Buy)	(5)	05/16/2032	Ordinary Shares	100,000	$0.025	D

Explanation of Responses:

1. The share options are fully vested and exercisable.

2. The share options vested as to 25% on April 27, 2024, and the remaining share options vest in equal monthly installments for three years thereafter.

3. The share options vested as to 25% on January 1, 2025, and the remaining share options vest in equal monthly installments for three years thereafter.

4. The share options vested as to 25% on November 25, 2025, and the remaining share options vest in equal monthly installments for three years thereafter.

5. The share options vest as to 25% on May 16, 2026, and the remaining share options vest in equal monthly installments for three years thereafter.

	/s/ Aaron Cameron	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does GH Research (GHRS) COO Cameron Luke report on this Form 3?

Cameron Aaron Luke reports his holdings of share options over Ordinary Shares. The filing lists multiple option grants with specific exercise prices, expiration dates, and vesting schedules, showing his potential equity exposure rather than any recent share purchases or sales.

How many GH Research share options does the COO hold in each grant?

The COO holds options over 33,211 underlying Ordinary Shares at one exercise price, 17,500 shares in a second grant, 25,000 shares in a third, 200,000 shares in a fourth, and 100,000 shares in a fifth, each with its own vesting and expiration terms.

What are the exercise prices of Cameron Luke’s GHRS share options?

His share options have exercise prices of $21.3200, $5.8000, and $0.0250 per Ordinary Share, depending on the specific grant. These fixed prices determine what he would pay per share if he chooses to exercise the options in the future.

When do the GH Research COO’s share options expire?

The option grants expire on different dates: August 30, 2029, April 27, 2030, January 1, 2032, November 25, 2031, and May 16, 2032. Each grant must be exercised, if at all, before its respective expiration date.

How do the GH Research COO’s share options vest over time?

One grant is already fully vested and exercisable. Other grants vest 25% on specific initial dates, such as April 27, 2024, January 1, 2025, November 25, 2025, or May 16, 2026, with the remaining 75% vesting in equal monthly installments over three years thereafter.